Tag: Medtronic

Medtronic announces trial data on closed-loop and DTM SCS therapies at...

At this year’s North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las Vegas, USA), Medtronic announced new data from two clinical trials demonstrating...

Medtronic receives CE-mark approval for Inceptiv closed-loop SCS to treat chronic...

Medtronic has received CE-mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator in the treatment of chronic pain. Inceptiv is the first Medtronic spinal...

Amazon executive joins Medtronic to spearhead development in robotics and implantables

Medtronic has announced that Ken Washington has been appointed chief technology and innovation officer. Washington joins Medtronic from Amazon where he served as vice president...

Medtronic receives FDA clearance for next-generation UNiD Spine Analyzer

Medtronic has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for its UNiD Spine Analyzer v4.0 planning platform, which...

Medtronic names Laura Mauri as new chief scientific, medical and regulatory...

Medtronic has announced that Laura Mauri has been appointed as the company’s chief scientific, medical and regulatory officer. This appointment adds to Mauri's prior responsibilities...

Medtronic announces FDA approval of spinal cord stimulation therapy for treating...

Medtronic has received US Food and Drug Administration (FDA) approval of its Intellis rechargeable neurostimulator and Vanta recharge-free neurostimulator for the treatment of chronic...

DTM spinal cord stimulation endurance therapy associated with meaningful pain relief...

Differential Target Multiplexed (DTM) spinal cord stimulation (SCS) endurance therapy provides meaningful pain relief according to three-month data from the DTM-LE trial—the findings of...

MedTech Insights: Covid-19 has “served as a catalyst” for a shift...

 Carlton Weatherby (Memphis, USA), vice president and general manager of spine and biologics at Medtronic, talks to Spinal News International about his own early...

Medtronic Canada unveils Mazor X, the first dedicated robotic spinal surgery...

Medtronic Canada has announced the commercial launch of the Mazor X system for robotic-guided spine surgery. The Mazor X platform offers a fully integrated...

University of Louisville and Medtronic team up to develop epidural stimulation...

A collaborative effort between the University of Louisville and Medtronic to apply epidural stimulation therapy to those with spinal cord injury has been given...

Medtronic bags FDA approval for Vanta implantable neurostimulator

Medtronic has received US Food and Drug Administration (FDA) approval for its Vanta device—a recharge-free implantable neurostimulator (INS) with a device life that Medtronic...

Medtronic receives FDA clearance for patient-specific UNiD Rods

Medtronic has announced that it has received US Food and Drug Administration (FDA) clearance of patient-specific UNiD Rods for use with its CD Horizon...

American Spine Registry expands sponsors with Medtronic addition

The American Association of Neurological Surgeons (AANS) and the American Academy of Orthopaedic Surgeons (AAOS) have announced that Medtronic has become the latest industry...

Medtronic launches spinal cord stimulation therapy mobile app

Medtronic has announced the launch of CareGuidePro, a new mobile application and web portal that serves as a virtual guide for patients throughout their...

Medtronic receives FDA approval for labelling of Intellis platform when using...

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the revised commercial labelling for the Intellis platform with differential target...

Medtronic announces first use in US of Midas Rex drills with...

Medtronic has announced the first use of Midas Rex drills and navigated disc prep and interbodies with the Mazor robotic guidance system for minimally-invasive...

BIBA Briefings: Medtronic continue to show faith in rhBMP-2 despite past...

The US Food and Drug Administration (FDA) has approved a new prospective, randomised clinical trial evaluating the use of recombinant human bone morphogenetic protein-2...

Medtronic announce new clinical trial to study Infuse bone graft in...

Medtronic today announced US Food and Drug Administration (FDA) approval of a prospective, randomised pivotal clinical trial for the use of Infuse bone graft...

National Osteoporosis Foundation supports new evidence-based vertebral compression fracture care pathway

Medtronic has announced that the National Osteoporosis Foundation (NOF) supports the vertebral compression fracture (VCF) Care Pathway, a new evidence-based clinical care pathway...

Omar Ishrak to step down as Medtronic CEO next year

Omar Ishrak, Medtronic’s chairman and CEO is to retire on 26 April 2020, following the end of the company’s current fiscal year. Also, the...
cns

Congress of Neurological Surgeons’ Top Paper of 2019 goes to spine...

The Congress of Neurological Surgeons (CNS) recently awarded their Top Paper of the Year and Spine Section Paper of the Year to an analysis...

Medtronic buys Titan Spine in bid to provide the “most comprehensive...

Medtronic has completed its acquisition of Titan Spine, which has a range of interbody fusion devices that feature unique surface technology. A press release...

Medtronic completes acquisition of Titan Spine

Medtronic today announced it has completed the acquisition of Titan Spine, a privately-held titanium spine interbody implant and surface technology company. A definitive acquisition...

Medtronic’s upcoming robot-assisted surgical platform to feature 3D vision systems

To enable upcoming regulatory filings, Medtronic has made public its partnership with Karl Storz, who have developed a system for endoscopic imaging. For the...

Medtronic enters into definitive agreement to acquire Titan Spine

Medtronic recently announced that it has entered into a definitive agreement pursuant to which it will acquire Titan Spine, a privately-held titanium spine interbody...
Mazor X

Medtronic announces US commercial launch of Mazor X Stealth Edition

The first US patients have been treated with the Mazor X Stealth Edition (Medtronic) for spine surgery following its commercial launch. The technology offers...

Medtronic completes acquisition of Mazor Robotics

Medtronic today announced it has completed the acquisition of Mazor Robotics. The total value of the transaction is reported at US$1.7 billion, or US$1.3 billion...

Mazor Robotics shareholders approve US$1.64B Medtronic transaction

Mazor Robotics has announced that at a Special General Meeting of Shareholders held on 19 November, 2018, Mazor shareholders approved the previously announced definitive...
Concorde

Global orthopaedic devices market worth US$47.7 billion by 2026

  The "Orthopaedic devices market size, share and trends analysis report by application (hip, knee, spine, cranio-maxillofacial, dental, SET), by product (accessories, surgical devices), and segment...
using robotics in spinal surgery

Costs curbing the rise of robotics in spinal surgery

The era of routine robotic-assisted spinal surgery is on the horizon. Despite the hype, however, there remains little market penetration, with affordability and the degree...
Medtronic

Medtronic launches the Infinity OCT spinal system

Medtronic has announced the US launch of the Infinity Occipitocervical-Upper Thoracic (OCT) System designed to simplify posterior cervical spine surgery. A company press release...
market

Spinal implants market to exceed US$19.5 billion by 2024

The global spinal implants market is forecast to grow at a 7% compound annual growth rate to exceed US$19.5 billion by 2024, according to...
Medtronic Mazor

Medtronic to acquire Mazor robotics

Medtronic and Mazor Robotics have announced that the two companies have entered into a definitive merger agreement under which Medtronic will acquire all outstanding...

Bone cement solution indicated for treating sacral fractures granted FDA approval

The US Food and Drug Administration (FDA) has granted 510(k) clearance of Kyphon HV-R bone cement (Medtronic) for fixation of pathological fractures of the...

FDA approval for Infuse Bone Graft in expanded spinal surgery indications

Infuse Bone Graft (Medtronic) has gained US Food and Drug Administration (FDA) approval in new spine surgery indications. InfuseBone Graft is now approved for...

Scoliosis Research Society collaborates with corporate partners and International Spine Study...

The Scoliosis Research Society (SRS) has partnered with Globus Medical, K2M, Medtronic, NuVasive, Zimmer Biomet, and the International Spine Study Group Foundation (ISSGF) to...
Metronic Intellis

Non-opioid alternative for chronic pain approved in Europe

A Conformité Européene (CE) Mark has been received by Medtronic for its neurostimulation platform Intellis for spinal cord stimulation (SCS) and peripheral nerve stimulation...
Mazor X

CE mark for Mazor X Surgical Assurance platform

Mazor Robotics has announced CE mark approval for its Mazor X Surgical Assurance Platform. The approval allows Mazor and its commercial partner, Medtronic, to...
Metronic Intellis

US FDA approves Medtronic’s Intellis spinal cord stimulation device

The US Food and Drug Administration has approved Medtronic’s Intellis spinal cord stimulator. The company has now launched the product in the USA for...

First patient enrolled in long-term Infuse posterolateral fusion study

Medtronic has announced the launch of a long-term clinical study programme to collect prospective data on rhBMP-2 (Infuse) bone graft in posterolateral fusion (PLF)...

Medtronic revises indications for use of Navlock trackers following patient deaths

Medtronic has updated the indications for use and the warning statements for its Navlock trackers, following two patient deaths. The trackers—which are part of...

Medtronic launches most advanced StealthStation for neurosurgery

Medtronic has launched its new StealthStation technology at the American Academy of Neurological Surgeons (AANS) annual conference in Los Angeles, USA. The new S8...
Medtronic logo

Medtronic announces new US bone cement indication for treating sacral fractures

Medtronic has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance of Kyphon Xpede bone cement for fixation of pathological...

Ohio judge dismisses hundreds of off-label Medtronic Infuse patient lawsuits

US district court judge, Timothy S Black (Southern Ohio, USA) has dismissed the accusation of several hundred plaintiffs that they have been treated off-label...

Medtronic completes US$20 million second tranche investment in Mazor Robotics

Medtronic has completed the second tranche of a previously agreed equity investment in Mazor Robotics. According to a press release, the triggering milestone for this...